|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.60/-0.20
|
企业价值
293.78M
|
资产负债 |
每股账面净值
0.53
|
现金流量 |
现金流量率
--
|
损益表 |
收益
82.51M
|
每股收益
1.49
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/21 20:59 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy. |